Table 2.
Results of cost-effectiveness evaluation over 260-week time horizon
| Reference case | |
|---|---|
| Total direct costs, $∗ | |
| TC | 133,721 |
| CM | 124,835 |
| Difference | 8,886 |
| Total costs including absenteeism, $∗ | |
| TC | 80,970 |
| CM | 90,567 |
| Difference | −9,597 |
| Total QALYs | |
| TC | 3.658 |
| CM | 3.412 |
| Difference | 0.246 |
| ICER ($ per QALY) | |
| Direct costs only, $∗ | 36,051 |
| Including absenteeism | DOMINANT |
CM, clinical management; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-years; QC, Quebec; TC, tight control.
All costs are in 2020 Canadian dollars.